58 related articles for article (PubMed ID: 19561641)
1. Post-translational modification and stability of low molecular weight cyclin E.
Mull BB; Cox J; Bui T; Keyomarsi K
Oncogene; 2009 Sep; 28(35):3167-76. PubMed ID: 19561641
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
[TBL] [Abstract][Full Text] [Related]
3. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
4. Processing of cyclin E differs between normal and tumor breast cells.
Harwell RM; Porter DC; Danes C; Keyomarsi K
Cancer Res; 2000 Jan; 60(2):481-9. PubMed ID: 10667604
[TBL] [Abstract][Full Text] [Related]
5. The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.
Yeh KH; Kondo T; Zheng J; Tsvetkov LM; Blair J; Zhang H
Biochem Biophys Res Commun; 2001 Mar; 281(4):884-90. PubMed ID: 11237742
[TBL] [Abstract][Full Text] [Related]
6. Akt isoform-specific inhibition of MDA-MB-231 cell proliferation.
Yang W; Ju JH; Lee KM; Shin I
Cell Signal; 2011 Jan; 23(1):19-26. PubMed ID: 20688159
[TBL] [Abstract][Full Text] [Related]
7. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
[TBL] [Abstract][Full Text] [Related]
8. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
9. The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo.
Bales E; Mills L; Milam N; McGahren-Murray M; Bandyopadhyay D; Chen D; Reed JA; Timchenko N; van den Oord JJ; Bar-Eli M; Keyomarsi K; Medrano EE
Cancer Res; 2005 Feb; 65(3):692-7. PubMed ID: 15705861
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation.
Xu X; Nakano T; Wick S; Dubay M; Brizuela L
Biochemistry; 1999 Jul; 38(27):8713-22. PubMed ID: 10393546
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
12. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation.
Lodén M; Nielsen NH; Roos G; Emdin SO; Landberg G
Oncogene; 1999 Apr; 18(16):2557-66. PubMed ID: 10353599
[TBL] [Abstract][Full Text] [Related]
13. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
[TBL] [Abstract][Full Text] [Related]
14. Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.
Spruck C; Sun D; Fiegl H; Marth C; Mueller-Holzner E; Goebel G; Widschwendter M; Reed SI
Cancer Res; 2006 Jul; 66(14):7355-60. PubMed ID: 16849587
[TBL] [Abstract][Full Text] [Related]
15. Why are the truncated cyclin Es more effective CDK2 activators than the full-length isoforms?
Rath SL; Senapati S
Biochemistry; 2014 Jul; 53(28):4612-24. PubMed ID: 24947816
[TBL] [Abstract][Full Text] [Related]
16. Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain.
Wang XD; Rosales JL; Magliocco A; Gnanakumar R; Lee KY
Oncogene; 2003 Feb; 22(5):769-74. PubMed ID: 12569370
[TBL] [Abstract][Full Text] [Related]
17. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.
Sueoka N; Lee HY; Walsh GL; Hong WK; Kurie JM
Cancer Res; 1999 Aug; 59(15):3838-44. PubMed ID: 10447003
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
Fåhraeus R; Laín S; Ball KL; Lane DP
Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
[TBL] [Abstract][Full Text] [Related]
20. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
Upton JW; van Dyk LF; Speck SH
Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
